Regulations.gov document
Exhibit 4 Medical Officer Review, Integrated Summary of Efficacy, Oxycodone Controlled…
Supporting & Related Material · FDA-2015-P-5108 · posted Dec 31, 2015
Key facts
| Document ID | FDA-2015-P-5108-0005 |
|---|---|
| Title | Exhibit 4 Medical Officer Review, Integrated Summary of Efficacy, Oxycodone Controlled Release, NDA 20553 and Medical officer Review, OxyContin Study 0402B-Cancer Pain re Citizen Petition from Purdue Pharma L.P. (Kleinfeld, Kaplan and Becker, LLP) |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2015-P-5108 |
| Posted | Dec 31, 2015 |
| Effective date | Dec 29, 2015 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: